Get started
Author

Masayoshi Ko

Observed name: Ko, Masayoshi
ORCID: 0000-0002-0792-0868
Observed ORCID: 0000-0002-0792-0868
OpenAlex ID: A5004837296
Perioperative monitoring of fluid responsiveness after esophageal surgery using stroke volume variation
2008 · Makoto Kobayashi, Masayoshi Ko, et al. · Expert Review of Medical Devices · 34
Diagnosis and management of fibromuscular dysplasia and segmental arterial mediolysis in gastroenterology field: A mini-review
2018 · Masayoshi Ko, Kenya Kamimura, et al. · World Journal of Gastroenterology · 33
PDF
Modulation of serotonin in the gut-liver neural axis ameliorates the fatty and fibrotic changes in non-alcoholic fatty liver
2021 · Masayoshi Ko, Kenya Kamimura, et al. · Disease Models & Mechanisms · 27
Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve
2016 · Toru Ishikawa, Michitaka Imai, et al. · Biomedical Reports · 25
PDF
Autonomic nervous system network and liver regeneration
2018 · Kenya Kamimura, Ryosuke Inoue, et al. · World Journal of Gastroenterology · 23
PDF
Rare Mesenteric Arterial Diseases: Fibromuscular Dysplasia and Segmental Arterial Mediolysis and Literature Review
2019 · Masayoshi Ko, Kenya Kamimura, et al. · Internal Medicine · 22
PDF
Inhibition of sodium glucose cotransporter 2 ( SGLT 2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis ( NASH )
2019 · Ryo Goto, Kenya Kamimura, et al. · FEBS Open Bio · 21
PDF
Evaluation of the branched-chain amino acid-to-tyrosine ratio prior to treatment as a prognostic predictor in patients with liver cirrhosis
2017 · Toru Ishikawa, Michitaka Imai, et al. · Oncotarget · 21
PDF
Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2A
2022 · Takashi Owaki, Kenya Kamimura, et al. · Disease Models & Mechanisms · 19
Letrozole ameliorates liver fibrosis through the inhibition of the CTGF pathway and 17β-hydroxysteroid dehydrogenase 13 expression
2022 · Norihiro Sakai, Kenya Kamimura, et al. · Journal of Gastroenterology · 16
Ghrelin‐insulin‐like growth factor‐1 axis is activated via autonomic neural circuits in the non‐alcoholic fatty liver disease
2020 · Takuro Nagoya, Kenya Kamimura, et al. · Neurogastroenterology & Motility · 10
Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease
2023 · Itsuo Nagayama, Kenya Kamimura, et al. · Hepatology International · 7
Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM–CHK2 Pathway
2022 · Yusuke Niwa, Kenya Kamimura, et al. · Journal of Clinical Medicine · 7
PDF
Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease
2019 · Takuro Nagoya, Kenya Kamimura, et al. · FEBS Open Bio · 7
PDF
Effect of Lenvatinib on a Hepatocellular Carcinoma with Fibroblast Growth Factor Receptor 4 Expression: A Case Report and Review of the Literature
2020 · Osamu Shibata, Kenya Kamimura, et al. · Internal Medicine · 6
PDF
Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status
2020 · Kentaro Tominaga, Kenya Kamimura, et al. · World Journal of Clinical Cases · 6
PDF
Effect of treatment support on preventing local recurrence of hepatocellular carcinoma directly adjacent to the diaphragm
2017 · Toru Ishikawa, Michitaka Imai, et al. · Molecular and Clinical Oncology · 4
PDF
Clinical usefulness of continuous central venous oxygen saturation measurement for postoperative management of patients following transthoracic esophagectomy for carcinoma
2011 · Makoto Kobayashi, Masayoshi Ko, et al. · Esophagus · 4
Relapsed refractory immune checkpoint inhibitor-induced colitis treated with tacrolimus and maintained with vedolizumab
2025 · Shohei Igarashi, Koji Shimaya, et al. · Clinical Journal of Gastroenterology · 3
[Hepatocellular carcinoma developing autoimmune hemolytic anemia after atezolizumab and bevacizumab combination therapy, transitioning to second-line treatment following improvement:a case report].
2025 · Masayoshi Ko, Kota Fujimaki, et al. · PubMed · 2
Hepatic splenosis mimicking hepatocellular carcinoma in a patient with chronic hepatitis C
2017 · Toru Ishikawa, Michitaka Imai, et al. · Global Imaging Insights · 2
PDF
Effects of Atezolizumab and Bevacizumab on Adrenal Gland Metastasis of Hepatocellular Carcinoma: A Case Report and Review of Literature
2022 · Natsuki Ishikawa, Kenya Kamimura, et al. · Internal Medicine · 1
PDF
Sequential Pancreatic Ascites and Hemosuccus Pancreaticus from an Identical Rupture Site in Branch-Duct Intraductal Papillary Mucinous Neoplasm: A Case Report
2026 · Seiya Sasakura, Masayoshi Ko, et al. · Case Reports in Gastroenterology
PDF
Successful Colonic Stenting Across the Ileocecal Valve With Severe Malignant Stenosis Using Ultra‐thin Scope and Single‐balloon Overtube
2025 · Takato Maeda, Norihiro Hanabata, et al. · DEN Open
PDF
Correction to: Complementary role of peripheral and central autonomic nervous system on insulin-like growth factor-1 activation to prevent fatty liver disease
2024 · Itsuo Nagayama, Kenya Kamimura, et al. · Hepatology International
PDF
Works count: 29
Citation count: 300
H-index: 10
I10-index: 11
Year
Topic
Type